IMMUNE BOSS (Health Boss Pty Ltd)
Product Name
IMMUNE BOSS
Sponsor
ARTG
Date of review outcome
Date of publication
Sep-2023
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Be aware that this medicine is not permitted by the TGA to make claims that it can slow down the ageing process, to prevent the development of cancer and heart disease, to reduce the susceptibility to infection and immune-related disorders, or as an anti-viral and anti-bacterial. Seek advice from a suitably qualified health practitioner if you have been or are intending to use this medicine for these purposes.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to supporting the production of collagen, reducing tiredness and fatigue, being anti-inflammatory, or supporting bones, cartilage, gums, skin and teeth health.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to supporting the production of collagen, reducing tiredness and fatigue, being anti-inflammatory, or supporting bones, cartilage, gums, skin and teeth health.
Review scope
Targeted
Information reviewed
ARTG Record, Website
Issues related to safety
The website for this medicine contained claims that it could help with the conditions specified in 'What action should consumers take?' above. These claims are not permitted for listed medicines without prior evaluation or approval from the TGA. References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a suitability qualified health professional when required, which may result in adverse outcomes. While advertising of this nature is unacceptable, these claims have been removed from the website. Furthermore, the website and the label for this medicine advise consumers to seek advice from a healthcare professional if symptoms persist. As such, this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The advertising for this medicine contained claims that it may help with the conditions specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor updated the website for this medicine to correct these issues.